nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RARB—cervical cancer	0.8	1	CbGaD
Alitretinoin—ABCB1—Topotecan—cervical cancer	0.0212	1	CbGbCtD
Alitretinoin—CRABP1—uterine cervix—cervical cancer	0.0032	0.0442	CbGeAlD
Alitretinoin—RARG—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00303	0.0425	CbGpPWpGaD
Alitretinoin—Isotretinoin—RARB—cervical cancer	0.00303	0.412	CrCbGaD
Alitretinoin—CRABP2—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.003	0.0421	CbGpPWpGaD
Alitretinoin—CRABP1—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.003	0.0421	CbGpPWpGaD
Alitretinoin—CRABP2—uterine cervix—cervical cancer	0.0029	0.04	CbGeAlD
Alitretinoin—CRABP1—mammalian vulva—cervical cancer	0.0028	0.0387	CbGeAlD
Alitretinoin—RXRG—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00277	0.0389	CbGpPWpGaD
Alitretinoin—CRABP2—decidua—cervical cancer	0.00276	0.0381	CbGeAlD
Alitretinoin—RARG—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.0027	0.0379	CbGpPWpGaD
Alitretinoin—RXRA—renal system—cervical cancer	0.0027	0.0372	CbGeAlD
Alitretinoin—CRABP2—endometrium—cervical cancer	0.00262	0.0362	CbGeAlD
Alitretinoin—RARA—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0026	0.0365	CbGpPWpGaD
Alitretinoin—RXRB—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.0026	0.0365	CbGpPWpGaD
Alitretinoin—Acitretin—RARB—cervical cancer	0.00257	0.351	CrCbGaD
Alitretinoin—CRABP2—mammalian vulva—cervical cancer	0.00253	0.035	CbGeAlD
Alitretinoin—RXRG—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00247	0.0347	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00244	0.0343	CbGpPWpGaD
Alitretinoin—CRABP1—female reproductive system—cervical cancer	0.0024	0.0331	CbGeAlD
Alitretinoin—RXRB—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00232	0.0326	CbGpPWpGaD
Alitretinoin—RARA—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00232	0.0326	CbGpPWpGaD
Alitretinoin—RXRB—decidua—cervical cancer	0.00227	0.0313	CbGeAlD
Alitretinoin—RARG—Nuclear Receptors—RARB—cervical cancer	0.00224	0.0314	CbGpPWpGaD
Alitretinoin—CRABP1—vagina—cervical cancer	0.00217	0.03	CbGeAlD
Alitretinoin—CRABP2—female reproductive system—cervical cancer	0.00217	0.03	CbGeAlD
Alitretinoin—RXRA—female reproductive system—cervical cancer	0.00216	0.0298	CbGeAlD
Alitretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.0021	0.0295	CbGpPWpGaD
Alitretinoin—RXRG—Nuclear Receptors—RARB—cervical cancer	0.00204	0.0287	CbGpPWpGaD
Alitretinoin—RARG—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00203	0.0284	CbGpPWpGaD
Alitretinoin—RARG—decidua—cervical cancer	0.00201	0.0278	CbGeAlD
Alitretinoin—CRABP2—female gonad—cervical cancer	0.00197	0.0273	CbGeAlD
Alitretinoin—RXRA—female gonad—cervical cancer	0.00197	0.0271	CbGeAlD
Alitretinoin—CRABP2—vagina—cervical cancer	0.00196	0.0271	CbGeAlD
Alitretinoin—RARB—female reproductive system—cervical cancer	0.00194	0.0268	CbGeAlD
Alitretinoin—RARA—Nuclear Receptors—RARB—cervical cancer	0.00192	0.027	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—RARB—cervical cancer	0.00192	0.027	CbGpPWpGaD
Alitretinoin—RARA—decidua—cervical cancer	0.00189	0.0261	CbGeAlD
Alitretinoin—RARA—renal system—cervical cancer	0.00186	0.0257	CbGeAlD
Alitretinoin—RXRG—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00185	0.026	CbGpPWpGaD
Alitretinoin—RARG—mammalian vulva—cervical cancer	0.00185	0.0255	CbGeAlD
Alitretinoin—RARA—endometrium—cervical cancer	0.0018	0.0248	CbGeAlD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00177	0.0248	CbGpPWpGaD
Alitretinoin—RARB—female gonad—cervical cancer	0.00177	0.0244	CbGeAlD
Alitretinoin—RARG—uterus—cervical cancer	0.00176	0.0243	CbGeAlD
Alitretinoin—RARB—vagina—cervical cancer	0.00176	0.0242	CbGeAlD
Alitretinoin—RARA—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00174	0.0244	CbGpPWpGaD
Alitretinoin—RXRB—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.00174	0.0244	CbGpPWpGaD
Alitretinoin—Tretinoin—RARB—cervical cancer	0.00174	0.237	CrCbGaD
Alitretinoin—RARA—uterus—cervical cancer	0.00166	0.0229	CbGeAlD
Alitretinoin—RXRB—female gonad—cervical cancer	0.00162	0.0224	CbGeAlD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00162	0.0227	CbGpPWpGaD
Alitretinoin—RXRB—vagina—cervical cancer	0.00161	0.0223	CbGeAlD
Alitretinoin—RARG—female reproductive system—cervical cancer	0.00158	0.0219	CbGeAlD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00152	0.0213	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00152	0.0213	CbGpPWpGaD
Alitretinoin—RARA—female reproductive system—cervical cancer	0.00149	0.0205	CbGeAlD
Alitretinoin—RARG—female gonad—cervical cancer	0.00144	0.0199	CbGeAlD
Alitretinoin—RARG—vagina—cervical cancer	0.00143	0.0198	CbGeAlD
Alitretinoin—Mucosal inflammation—Topotecan—cervical cancer	0.00138	0.0491	CcSEcCtD
Alitretinoin—RXRA—RXR and RAR heterodimerization with other nuclear receptor—RARB—cervical cancer	0.00136	0.019	CbGpPWpGaD
Alitretinoin—RARA—female gonad—cervical cancer	0.00135	0.0187	CbGeAlD
Alitretinoin—Febrile neutropenia—Topotecan—cervical cancer	0.00127	0.0452	CcSEcCtD
Alitretinoin—RXRA—Retinoic acid receptors-mediated signaling—RARB—cervical cancer	0.00121	0.017	CbGpPWpGaD
Alitretinoin—RARB—lymph node—cervical cancer	0.00114	0.0157	CbGeAlD
Alitretinoin—Lung disorder—Topotecan—cervical cancer	0.00108	0.0384	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptors—RARB—cervical cancer	0.001	0.0141	CbGpPWpGaD
Alitretinoin—Pleural effusion—Topotecan—cervical cancer	0.000999	0.0355	CcSEcCtD
Alitretinoin—RARG—lymph node—cervical cancer	0.000926	0.0128	CbGeAlD
Alitretinoin—RXRA—Vitamin A and Carotenoid Metabolism—RARB—cervical cancer	0.000908	0.0127	CbGpPWpGaD
Alitretinoin—RARA—lymph node—cervical cancer	0.000871	0.012	CbGeAlD
Alitretinoin—Blood bilirubin increased—Topotecan—cervical cancer	0.000808	0.0287	CcSEcCtD
Alitretinoin—Bone pain—Topotecan—cervical cancer	0.000798	0.0284	CcSEcCtD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000792	0.0111	CbGpPWpGaD
Alitretinoin—Respiratory failure—Topotecan—cervical cancer	0.000779	0.0277	CcSEcCtD
Alitretinoin—Colitis—Topotecan—cervical cancer	0.000734	0.0261	CcSEcCtD
Alitretinoin—Rash maculo-papular—Topotecan—cervical cancer	0.000695	0.0247	CcSEcCtD
Alitretinoin—CYP1A2—renal system—cervical cancer	0.000689	0.00951	CbGeAlD
Alitretinoin—Sepsis—Topotecan—cervical cancer	0.000664	0.0236	CcSEcCtD
Alitretinoin—Ear pain—Topotecan—cervical cancer	0.000651	0.0231	CcSEcCtD
Alitretinoin—Dermatitis bullous—Topotecan—cervical cancer	0.000581	0.0206	CcSEcCtD
Alitretinoin—Lethargy—Topotecan—cervical cancer	0.000566	0.0201	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000528	0.00741	CbGpPWpGaD
Alitretinoin—Cardiac arrest—Topotecan—cervical cancer	0.000528	0.0188	CcSEcCtD
Alitretinoin—Neutropenia—Topotecan—cervical cancer	0.000449	0.0159	CcSEcCtD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000438	0.00614	CbGpPWpGaD
Alitretinoin—Weight increased—Topotecan—cervical cancer	0.000437	0.0155	CcSEcCtD
Alitretinoin—Pneumonia—Topotecan—cervical cancer	0.00043	0.0153	CcSEcCtD
Alitretinoin—Infestation NOS—Topotecan—cervical cancer	0.000428	0.0152	CcSEcCtD
Alitretinoin—Infestation—Topotecan—cervical cancer	0.000428	0.0152	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Topotecan—cervical cancer	0.000419	0.0149	CcSEcCtD
Alitretinoin—Stomatitis—Topotecan—cervical cancer	0.000417	0.0148	CcSEcCtD
Alitretinoin—Sweating—Topotecan—cervical cancer	0.00041	0.0146	CcSEcCtD
Alitretinoin—Epistaxis—Topotecan—cervical cancer	0.000403	0.0143	CcSEcCtD
Alitretinoin—Haemoglobin—Topotecan—cervical cancer	0.000386	0.0137	CcSEcCtD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	0.000385	0.00541	CbGpPWpGaD
Alitretinoin—Haemorrhage—Topotecan—cervical cancer	0.000384	0.0137	CcSEcCtD
Alitretinoin—Hypoaesthesia—Topotecan—cervical cancer	0.000382	0.0136	CcSEcCtD
Alitretinoin—Pharyngitis—Topotecan—cervical cancer	0.000381	0.0135	CcSEcCtD
Alitretinoin—ABCB1—epithelium—cervical cancer	0.000381	0.00525	CbGeAlD
Alitretinoin—RXRA—Developmental Biology—INSM1—cervical cancer	0.00038	0.00534	CbGpPWpGaD
Alitretinoin—ABCB1—uterine cervix—cervical cancer	0.000377	0.00521	CbGeAlD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	0.000362	0.00508	CbGpPWpGaD
Alitretinoin—ABCB1—decidua—cervical cancer	0.00036	0.00496	CbGeAlD
Alitretinoin—ABCB1—renal system—cervical cancer	0.000353	0.00487	CbGeAlD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000349	0.0049	CbGpPWpGaD
Alitretinoin—Angiopathy—Topotecan—cervical cancer	0.000348	0.0124	CcSEcCtD
Alitretinoin—Chills—Topotecan—cervical cancer	0.000345	0.0122	CcSEcCtD
Alitretinoin—ABCB1—endometrium—cervical cancer	0.000341	0.00471	CbGeAlD
Alitretinoin—Alopecia—Topotecan—cervical cancer	0.000339	0.0121	CcSEcCtD
Alitretinoin—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000337	0.00472	CbGpPWpGaD
Alitretinoin—Malnutrition—Topotecan—cervical cancer	0.000334	0.0119	CcSEcCtD
Alitretinoin—ABCB1—mammalian vulva—cervical cancer	0.00033	0.00456	CbGeAlD
Alitretinoin—Back pain—Topotecan—cervical cancer	0.000323	0.0115	CcSEcCtD
Alitretinoin—ABCB1—uterus—cervical cancer	0.000315	0.00434	CbGeAlD
Alitretinoin—Ill-defined disorder—Topotecan—cervical cancer	0.00031	0.011	CcSEcCtD
Alitretinoin—Anaemia—Topotecan—cervical cancer	0.000309	0.011	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—RARB—cervical cancer	0.000305	0.00428	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000303	0.00425	CbGpPWpGaD
Alitretinoin—Malaise—Topotecan—cervical cancer	0.000301	0.0107	CcSEcCtD
Alitretinoin—Cough—Topotecan—cervical cancer	0.000292	0.0104	CcSEcCtD
Alitretinoin—Arthralgia—Topotecan—cervical cancer	0.000285	0.0101	CcSEcCtD
Alitretinoin—Chest pain—Topotecan—cervical cancer	0.000285	0.0101	CcSEcCtD
Alitretinoin—Myalgia—Topotecan—cervical cancer	0.000285	0.0101	CcSEcCtD
Alitretinoin—ABCB1—female reproductive system—cervical cancer	0.000283	0.0039	CbGeAlD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000283	0.01	CcSEcCtD
Alitretinoin—Discomfort—Topotecan—cervical cancer	0.000281	0.01	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—RARB—cervical cancer	0.000279	0.00392	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000275	0.00386	CbGpPWpGaD
Alitretinoin—Anaphylactic shock—Topotecan—cervical cancer	0.000273	0.0097	CcSEcCtD
Alitretinoin—Infection—Topotecan—cervical cancer	0.000271	0.00964	CcSEcCtD
Alitretinoin—Nervous system disorder—Topotecan—cervical cancer	0.000268	0.00951	CcSEcCtD
Alitretinoin—Thrombocytopenia—Topotecan—cervical cancer	0.000267	0.0095	CcSEcCtD
Alitretinoin—Skin disorder—Topotecan—cervical cancer	0.000265	0.00942	CcSEcCtD
Alitretinoin—Hyperhidrosis—Topotecan—cervical cancer	0.000264	0.00938	CcSEcCtD
Alitretinoin—RARA—Generic Transcription Pathway—RARB—cervical cancer	0.000262	0.00368	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—RARB—cervical cancer	0.000262	0.00368	CbGpPWpGaD
Alitretinoin—Anorexia—Topotecan—cervical cancer	0.00026	0.00925	CcSEcCtD
Alitretinoin—ABCB1—female gonad—cervical cancer	0.000257	0.00355	CbGeAlD
Alitretinoin—ABCB1—vagina—cervical cancer	0.000256	0.00353	CbGeAlD
Alitretinoin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000249	0.00884	CcSEcCtD
Alitretinoin—Paraesthesia—Topotecan—cervical cancer	0.000245	0.00871	CcSEcCtD
Alitretinoin—Dyspnoea—Topotecan—cervical cancer	0.000243	0.00865	CcSEcCtD
Alitretinoin—Dyspepsia—Topotecan—cervical cancer	0.00024	0.00854	CcSEcCtD
Alitretinoin—Decreased appetite—Topotecan—cervical cancer	0.000237	0.00843	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Topotecan—cervical cancer	0.000236	0.00837	CcSEcCtD
Alitretinoin—Fatigue—Topotecan—cervical cancer	0.000235	0.00836	CcSEcCtD
Alitretinoin—Constipation—Topotecan—cervical cancer	0.000233	0.00829	CcSEcCtD
Alitretinoin—Pain—Topotecan—cervical cancer	0.000233	0.00829	CcSEcCtD
Alitretinoin—Feeling abnormal—Topotecan—cervical cancer	0.000225	0.00799	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Topotecan—cervical cancer	0.000223	0.00793	CcSEcCtD
Alitretinoin—Urticaria—Topotecan—cervical cancer	0.000217	0.00771	CcSEcCtD
Alitretinoin—Abdominal pain—Topotecan—cervical cancer	0.000216	0.00767	CcSEcCtD
Alitretinoin—Body temperature increased—Topotecan—cervical cancer	0.000216	0.00767	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—CTNNB1—cervical cancer	0.000208	0.00292	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000206	0.00289	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000202	0.00284	CbGpPWpGaD
Alitretinoin—Hypersensitivity—Topotecan—cervical cancer	0.000201	0.00715	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—CA9—cervical cancer	0.000199	0.00279	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CA9—cervical cancer	0.000199	0.00279	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000197	0.00277	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—CTNNB1—cervical cancer	0.000196	0.00275	CbGpPWpGaD
Alitretinoin—Asthenia—Topotecan—cervical cancer	0.000196	0.00696	CcSEcCtD
Alitretinoin—Pruritus—Topotecan—cervical cancer	0.000193	0.00686	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	0.000189	0.00265	CbGpPWpGaD
Alitretinoin—Diarrhoea—Topotecan—cervical cancer	0.000187	0.00664	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000185	0.00259	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—STAT3—cervical cancer	0.000182	0.00255	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000181	0.00254	CbGpPWpGaD
Alitretinoin—Dizziness—Topotecan—cervical cancer	0.00018	0.00641	CcSEcCtD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000179	0.00251	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000174	0.00244	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000174	0.00244	CbGpPWpGaD
Alitretinoin—Vomiting—Topotecan—cervical cancer	0.000173	0.00617	CcSEcCtD
Alitretinoin—Rash—Topotecan—cervical cancer	0.000172	0.00612	CcSEcCtD
Alitretinoin—Dermatitis—Topotecan—cervical cancer	0.000172	0.00611	CcSEcCtD
Alitretinoin—Headache—Topotecan—cervical cancer	0.000171	0.00608	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—STAT3—cervical cancer	0.000171	0.00239	CbGpPWpGaD
Alitretinoin—ABCB1—lymph node—cervical cancer	0.000165	0.00228	CbGeAlD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000163	0.00229	CbGpPWpGaD
Alitretinoin—Nausea—Topotecan—cervical cancer	0.000162	0.00576	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000156	0.00218	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00015	0.00211	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000149	0.00209	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	0.000149	0.00209	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—RARB—cervical cancer	0.000147	0.00206	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000144	0.00202	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—RARB—cervical cancer	0.000137	0.00192	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—RARB—cervical cancer	0.000134	0.00189	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	0.000127	0.00179	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—RARB—cervical cancer	0.000126	0.00177	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—RARB—cervical cancer	0.000126	0.00177	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000125	0.00176	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000123	0.00172	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000119	0.00167	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000114	0.00161	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000114	0.0016	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000112	0.00157	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00011	0.00154	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000108	0.00151	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000108	0.00151	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000103	0.00144	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—CTNNB1—cervical cancer	0.000102	0.00143	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	9.98e-05	0.0014	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NOTCH2—cervical cancer	9.73e-05	0.00137	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	9.57e-05	0.00134	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH2—cervical cancer	9.06e-05	0.00127	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NOTCH2—cervical cancer	8.9e-05	0.00125	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—STAT3—cervical cancer	8.89e-05	0.00125	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NOTCH2—cervical cancer	8.73e-05	0.00122	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NOTCH2—cervical cancer	8.37e-05	0.00117	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NOTCH2—cervical cancer	8.37e-05	0.00117	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP8—cervical cancer	8.33e-05	0.00117	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—MTHFR—cervical cancer	8.07e-05	0.00113	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—MTHFR—cervical cancer	8.07e-05	0.00113	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	7.78e-05	0.00109	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	7.5e-05	0.00105	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HES1—cervical cancer	6.99e-05	0.000981	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—RARB—cervical cancer	6.59e-05	0.000924	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—CASP3—cervical cancer	6.3e-05	0.000884	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NOTCH1—cervical cancer	6.02e-05	0.000845	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CA9—cervical cancer	6.02e-05	0.000845	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	5.94e-05	0.000834	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	5.92e-05	0.000831	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	5.92e-05	0.000831	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH1—cervical cancer	5.61e-05	0.000787	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NOTCH1—cervical cancer	5.51e-05	0.000773	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NOTCH1—cervical cancer	5.4e-05	0.000758	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NOTCH1—cervical cancer	5.28e-05	0.000741	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NOTCH1—cervical cancer	5.18e-05	0.000727	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NOTCH1—cervical cancer	5.18e-05	0.000727	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	4.99e-05	0.0007	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH2—cervical cancer	4.36e-05	0.000612	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	4.11e-05	0.000577	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—cervical cancer	3.51e-05	0.000492	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	3.11e-05	0.000436	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—cervical cancer	3.06e-05	0.000429	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	3e-05	0.000421	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—cervical cancer	2.78e-05	0.00039	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH1—cervical cancer	2.7e-05	0.000379	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—MTHFR—cervical cancer	2.44e-05	0.000343	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CA9—cervical cancer	2.41e-05	0.000338	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	2.37e-05	0.000333	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.99e-05	0.00028	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CA9—cervical cancer	1.92e-05	0.00027	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTHFR—cervical cancer	9.77e-06	0.000137	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTHFR—cervical cancer	7.8e-06	0.000109	CbGpPWpGaD
